Efficacy and tolerability of oral versus injectable disease-modifying therapies for multiple sclerosis in clinical practice:

Multiple Sclerosis Journal – Experimental, Translational and Clinical

Amber Salter¹  Anne H Cross¹  Erin E Longbrake² 

[1] Department of Neurology, Washington University in St. Louis, USA;Department of Neurology, Yale University, USA

关键词: Multiple sclerosis;    disease modifying therapy;    dimethyl fumarate;    teriflunomide;    fingolimod;    tolerability;   

DOI  :  10.1177/2055217316677868

学科分类：医学（综合）

来源: Sage Journals

【 授权许可】

CC BY-NC